APA (7th ed.) Citation

Sehouli, J., Reinthaller, A., Marth, C., Reimer, D., Reimer, T., Stummvoll, W., . . . Chekerov, R. (2014). Intra- and postoperative catumaxomab in patients with epithelial ovarian cancer: Safety and two-year efficacy results from a multicentre, single-arm, phase II study. British Journal of Cancer, 111(8), 1519. https://doi.org/10.1038/bjc.2014.443

Chicago Style (17th ed.) Citation

Sehouli, J., A. Reinthaller, C. Marth, D. Reimer, T. Reimer, W. Stummvoll, L. Angleitner-Boubenizek, B. Brandt, and R. Chekerov. "Intra- and Postoperative Catumaxomab in Patients with Epithelial Ovarian Cancer: Safety and Two-year Efficacy Results from a Multicentre, Single-arm, Phase II Study." British Journal of Cancer 111, no. 8 (2014): 1519. https://doi.org/10.1038/bjc.2014.443.

MLA (9th ed.) Citation

Sehouli, J., et al. "Intra- and Postoperative Catumaxomab in Patients with Epithelial Ovarian Cancer: Safety and Two-year Efficacy Results from a Multicentre, Single-arm, Phase II Study." British Journal of Cancer, vol. 111, no. 8, 2014, p. 1519, https://doi.org/10.1038/bjc.2014.443.